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ABSTRACT 
DRUG UTILIZATION PATTERN OF ANTIARRHYTHMIA 
IN PATIENTS WITH HEART FAILURE 
Ratna Lutfi Fatmawati 
 Heart failure is a clinical syndrome in which the heart is unable 
to pump blood to meet the body’s metabolism. Arrhythmia is commonly 
occurred in heart failure. Arrhythmia is a heart rhythm disorder 
characterized by absence of clear P waves on ECG and abnormal 
heartbeat. This study discussed about amiodarone (rhythm controll), 
digoxin and bisoprolol  (rate control) for management therapy of 
arrhythmia in patient with heart failure. This study aimed to review the 
use of antiarrhythmia drugs in patients with heart failure in cardiovascular 
unit of Teaching Hospital  Surabaya from January 1 to December 31, 
2017. This study was an observational retrospective conducted by 
examining the drug utilization data from the patient medical record. There 
were 36 patients diagnosed with heart failure and received amiodarone, 
digoxin and beta-blocker. The most widely used drug was digoxin 
(61.1%) and bisoprolol (25%) as rate controlling agent. Amiodarone 
(13.8%) was used as rhythm controlling agent. The combination found in 
this study were amiodarone and digoxin (2.7%), amiodarone and 
bisoprolol (5.5%), digoxin and bisoprolol (11.1%). The dosage of 
amiodarone, digoxin and bisoprolol were different for each patient and 
depend on their clinical features. In addition, the route of administration 
foramiodarone and digoxin were peroral and intravenous injection, which 
consistsed of loading dose and maintenance dose. There were no drug 
related problems (DRPs) identified. The potential interactions between 
antiarrhythmia agents and other concomitant drugs were the increase of 
anticoagulant effect of warfarin, decrease antihypertension effect of 
bisoprolol  and increase of serum digoxin concentration. The use of 
amiodarone, digoxin and bisoprolol either in single or combination 
therapy were in accordance with the National guidelines for treatment and 
therapy for arrhythmia, including appropriate dose, frequency and route 
of administration.  
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